The results of a randomized controlled trial (RTC) may offer new opportunities for the approximately two million patients with chronic wounds solely in Germany: The innovative cold atmospheric plasmajet (CAP-jet) technology showed significantly more healing progress in chronic wounds in comparison to best practice (BP) modern wound care at two study centers. Within six weeks,…

eTurboNews články sú len pre predplatiteľov. Predplatné je ZADARMO.
Odberatelia sa prihlasujú tu Kliknite sem a prihláste sa na odber ZDARMA

ČO SI Z TOHTO ČLÁNKU ODniesť:

The innovative cold atmospheric plasmajet (CAP-jet) technology showed significantly more healing progress in chronic wounds in comparison to best practice (BP) modern wound care at two study centers.
The results of a randomized controlled trial (RTC) may offer new opportunities for the approximately two million patients with chronic wounds solely in Germany.
eTurboNews články sú len pre predplatiteľov.